Targeting macrophagic SHP2 for ameliorating osteoarthritis via TLR signaling
Osteoarthritis (OA), in which M1 macrophage polarization in the synovium exacerbates disease progression, is a major cause of cartilage degeneration and functional disabilities. Therapeutic strategies of OA designed to interfere with the polarization of macrophages have rarely been reported. Here, w...
| Published in: | Acta Pharmaceutica Sinica B |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-07-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383522000600 |
